IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now
IM Cannabis
Medical cannabis company IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30, 2024, on Wednesday, Aug. 14, 2024.
The company said it will host a Zoom web conference on the same day at 9:00 am ET to discuss the results, followed by a question-and-answer session for the investment community.
The company announced a major share consolidation plan last month. Its board of directors approved a consolidation of its issued and outstanding common shares under which every six pre-consolidated common shares will convert into one post-consolidated share. The strategic decision reduced its outstanding shares from 13,394,136 to 2,232,357, making the stock more attractive to institutional investors and improving liquidity.
IMCC’s shares were trading 7.14% higher at $3 per share at the time of the writing on Tuesday.
cbdMD
cbdMD, Inc. (NYSE: YCBD) said it will host a conference call at 4:20 pm ET on Wednesday, Aug. 14, 2024, to discuss the company’s June 30, 2024 third quarter of fiscal 2024 financial results and business progress.
In May, the company reported an increase in operational losses from $1.4 million in the second quarter of fiscal 2023 to $1.5 million in the second quarter of fiscal 2024. Yet …